NEW YORK (GenomeWeb) – Boulder, Colorado-based MBio Diagnostics has received a $217,702 grant from the National Science Foundation to develop toxin testing technology.

The grant funds development of a portable platform to detect algal bloom toxins using the firm's multiplexed fluorescence immunoassay Array System and LightDeck fluorescence assay illumination technology.

"MBio has demonstrated a unique, portable testing platform that delivers a panel of freshwater and marine toxin test results in a matter of minutes in an easy-to-use format," the firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.